Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
SYRE
SYRE News & Events
-
Add to Watchlist
Trade SYRE
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
SYRE News
Spyre Therapeutics Prices Public Offering at $62 per Share
Apr 15 2026
NASDAQ.COM
Spyre Therapeutics Upsizes Public Offering to Raise $403 Million
Apr 15 2026
seekingalpha
Spyre Therapeutics Prices $403 Million Public Offering
Apr 15 2026
Yahoo Finance
Spyre Therapeutics Prices Public Offering at $62 per Share
Apr 15 2026
Newsfilter
Spyre Therapeutics Launches $300 Million Public Offering
Apr 14 2026
NASDAQ.COM
Spyre Therapeutics Launches $300M Public Offering to Fund Drug Development
Apr 13 2026
seekingalpha
Spyre Therapeutics Launches $300 Million Public Offering
Apr 13 2026
Newsfilter
Spyre Therapeutics' Trial Data Boosts Stock by 23%
Apr 13 2026
stocktwits
Show More News
SYRE Events
04/15 05:50
Deal Size Increased to $403M in Common Stock
The deal size was increased to $403M in common stock from $300M in common stock. Jefferies, Goldman Sachs, Evercore ISI and Guggenheim acted as joint book running managers for the offering.
Show More Events
SYRE Monitor News
Spyre Therapeutics stock rises after crossing above SMA
Apr 29 2026
Spyre Therapeutics CEO sells shares amid clinical trial advancements
Apr 13 2026
SYRE Earnings Analysis
No Data
People Also Watch
